Sophie V. Vandebroek - May 4, 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sophie V. Vandebroek
Stock symbol
IDXX
Transactions as of
May 4, 2023
Transactions value $
-$573,862
Form type
4
Date filed
5/5/2023, 06:01 PM
Previous filing
May 13, 2022
Next filing
May 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $452K +2.19K +250.8% $206.62 3.06K May 4, 2023 Direct
transaction IDXX Common Stock Sale -$1.03M -2.19K -71.49% $469.02 872 May 4, 2023 Direct F1
transaction IDXX Common Stock Gift $0 -500 -5.77% $0.00 8.17K May 4, 2023 By Sophie V. Vandebroek Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -2.19K -100% 0 May 4, 2023 Common Stock 2.19K $206.62 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold ranging from a low of $469.00 to a high of $469.15 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F2 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event was earlier.
F3 Not applicable.